February 20, 2025 – Hummingbird Healthcare Inc. successfully closed a $20 million Series B funding round led by Health Velocity Capital. Hummingbird is a managed services company focused on elevating patient access to healthcare and creating good jobs. This investment ensures Hummingbird has the resources to continue scaling technology, processes, and people to help their health system clients modernize patient access.
“From the beginning, we knew that both healthcare systems and patients wanted a more logical and humane access experience,” said Jeremy Schwach, Hummingbird’s CEO. “The pace of Hummingbird’s growth and our clients’ trust demonstrate just how huge that need is.” Hummingbird’s current round of investment follows closely a Series A round that closed in June 2024.
Focused on maximizing the adoption of core technologies like Epic, Hummingbird helps clients standardize primary care and specialty patient access services into centralized contact centers, improve contact center operations, and optimize access technology.
“Health Velocity Capital has 25 years of experience backing healthcare startups that have become market leaders. They have a depth of maturity in understanding both the market and the economic challenges in healthcare,” said Schwach. “That type of experience will be invaluable as Hummingbird focuses on sustainable growth and keeping our promises to both clients and employees.”
Resonant with Hummingbird’s mission to improve patient access, Health Velocity Capital invests solely in innovative healthcare software and services businesses to create a more affordable, sustainable, and consumer-friendly future.
“All of us at Health Velocity Capital are thrilled to lead Hummingbird Healthcare’s latest funding round and support their mission to transform patient access to care. We believe that AI-enabled managed services are the future of customer service and other human capital-intensive business functions within enterprises. Hummingbird Healthcare is reimagining patient access with a unique combination of technology, Epic optimization, and business process outsourcing,” said Grant Blevins, a partner at Health Velocity Capital. “We could not imagine a better team to solve this problem and are honored to be partners with Jeremy, Raychel [Haberer, President], and the entire Hummingbird team.”
Blevins will be joining as a member of the Hummingbird board of directors, lending valuable insight from years of investing in healthcare firms. In addition, Kristin Torres Mowat, also a Health Velocity Capital partner, will be joining the board as an observer.
Joining Health Velocity Capital in this round of investment is a diverse set of investors including returning investors UCHealth and the CU Healthcare Innovation Fund. Having previously invested in the seed and Series A funding rounds, UCHealth is both an investor and strategic client partner of Hummingbird’s, working together to assess, improve, and operate key areas of UCHealth’s industry-leading patient access services.
ABOUT HUMMINGBIRD HEALTHCARE AND ITS INVESTMENT PARTNERS
Hummingbird is a healthcare managed services company that specializes in patient access, including appointment scheduling, registration, insurance verification, authorizations and referrals, nurse triage, and prescription management. Their goal is to reduce the $30 billion health systems spend every year answering phone calls by managing patient access as a technology-enabled service to provide patients with the responsive, personalized experience they’ve come to expect in other industries. Hummingbird also focuses on creating good jobs that attract and keep talent in healthcare. As a member of the Good Jobs Institute, Hummingbird’s operating philosophy is rooted in the Good Jobs Strategy, where paying front-line team members living wages, investing in learning and development, and committing to internal mobility are key to enduring success.
Health Velocity Capital invests exclusively in innovative healthcare software and services companies. The firm’s partners have more than 90 collective years as investors, entrepreneurs, and executives helping to finance and build innovative companies that created important new healthcare markets and that became market leaders, including successful companies such as Teladoc, Livongo Health, Change Healthcare, MDLive, Contessa Health, Headspace Health, Aspire Health, Zipari, IVX Health, Artera (fka Well Health), Compassus, Aperio, The Advisory Board Company, Healthways (Tivity Health), US Renal Care, Spero Health, OnShift, and many others. The firm counts among its limited partners many of the largest and most influential healthcare organizations in the country and current and former senior healthcare executives who collectively represent organizations that insure more than 175 million Americans, operate more than 700 hospitals, provide pharmacy and PBM services to everyone in the United States, and sell software to every major US health system.
Contact:
Justin Jozwik, Senior Leader, Growth
608.332.8782, justin@hummingbird.healthcare